Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...

Related Keywords

Germany ,China ,Hong Kong ,Israel ,Bonn ,Nordrhein Westfalen ,Hangzhou ,Zhejiang ,Chinese ,Amir Gross ,Eric Zi ,Edwards Lifesciences ,Francesco Maisano ,Venus Medtech ,Valve Center ,San Raffaele University Hospital ,Venus Medtech Hangzhou Inc ,Cardiovalve Ltd ,Piedmont Heart Institute ,Prnewswire Venus Medtech Hangzhou Inc ,Mitraltech Ltd ,Valgen Holding Corporation ,European Society Of Cardiology ,University Heart Center ,Center University Clinic Bonn ,Valtech Cardio ,Cardiovalve System ,San Donato ,Universitaet Mainz ,Heart Center University Clinic Bonn ,Medical Clinic ,Breakthrough Device Designation ,Cardiac Surgery ,Valve Clinic ,Raffaele University Hospital ,European Society ,Scott Lim ,Cardiac Valve Center ,Main Board ,Hong Kong Stock Exchange ,Health Care Amp Hospitals ,Medical Equipment ,Medical Pharmaceuticals ,Acquisitions ,Ergers And Takeovers ,